Matthias Weigel1,2,3, Riccardo Galbusera1,2, Reza Rahmanzadeh1,2, Muhamed Barakovic1,2, Po-Jui Lu1,2, Ludwig Kappos2, Wolfgang Brück4, Tobias Kober5,6,7, Peter Dechent8, and Cristina Granziera1,2
1Translational Imaging in Neurology (ThINk) Basel, Department of Medicine and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland, 2Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland, 3Radiological Physics, Department of Radiology, University Hospital Basel, Basel, Switzerland, 4Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany, 5Advanced Clinical Imaging Technology, Siemens Healthcare, Lausanne, Switzerland, 6Department of Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland, 7LTS5, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland, 8Department of Cognitive Neurology, MR-Research in Neurology and Psychiatry, University Medical Center Göttingen, Göttingen, Germany
Synopsis
The MP2RAGE sequence provides fast volumetric T1 weighted MR imaging and offers the possibility to reconstruct quantitative T1 maps. Therefore, it is frequently applied for studying Multiple Sclerosis pathologies in recent years. The present work investigates and explains necessary protocol changes for applying MP2RAGE in fixated human brain acquisitions. Using the established protocol, it is shown that strong soft tissue contrast is reinstated and quantitative T1 values can be derived for normal appearing gray matter and lesions. Based on the feasibility of using long scan times, the isotropic resolution of the MP2RAGE could be even increased to 0.75mm.
Introduction
The MP2RAGE sequence is an advancement
of the magnetization prepared rapid gradient echo (MPRAGE1) sequence,
which provides fast volumetric T1 weighted MR imaging with minimized sensitivity
to excitation field, reception bias field, proton density, and T2* contrast2.
In recent years, MP2RAGE acquisitions have been applied in clinical research to
assess cortical and white matter pathology in Multiple Sclerosis (MS) patients both
at 3T and 7T MRI3,4.
In this work, obligatory parameter changes to harness the MP2RAGE
capabilities for postmortem fixated whole-brain MR imaging at 3T field strength
are investigated. The resulting optimized protocol was employed for the MRI of
three fixated brains of patients who had suffered from MS.Methods
The brain of three patients with
secondary progressive MS were fixated in 10% formalin 24h to 48h after autopsy.
For MRI acquisition, the brains were positioned in a dome-shaped container as depicted
in 5-7 and immersed in a fluorinated oil (i.e. Fomblin). Air bubbles
were aspirated through the spout of the container through a vacuum pump. All
acquisitions were performed with a 3T wholebody MR system (Prismafit,
Siemens Healthcare, Erlangen, Germany) using a 20-channel head coil.
For a successful MP2RAGE
implementation, as a minimum requirement, the sampling conditions must be
adapted to the present T1 tissue relaxation times. A pre-assessment showed that
the tissue T1 relaxation times can be as low as approx. 200ms in the measured
brains at 3T. This observation posed a challenge for two reasons: (1) Low T1
relaxation times lead to fast signal changes during sampling, which eventually
have a detrimental effect on the point spread function PSF (“T1 blurring”). (2)
Short inversion times TI1 are needed for generating optimal brain
tissue contrast. However, sub-millimeter spatial resolutions for the detection
of small intracortical lesions are desired, which generally necessitate even longer
readout times.
As a result, the following acquisition
protocol was developed that addresses the requirements of this specific
application: FOV=192x138x156mm3, a sagittal 3D slab of full isotropic
0.75mm resolution, 2D phase inside-3D phase outside-encoding scheme
(“rotated”), parallel acquisition (GRAPPA) factor=3, ACS lines=32, bandwidth=700Hz/Pixel,
ESP=4.2ms, TR=2700ms, TI1=194ms, TI2=2500ms, flip angles 6°
and 7°, respectively, signal averaging=20, total acquisition time=3h 07min
12sec.
MS lesions (intracortical, leuco-cortical and juxtacortical) were
identified by two independent readers on MP2RAGE uniform images.Results
The developed solution uses quite unusual protocol settings for a
MP2RAGE sequence: a high readout bandwidth of 700Hz/Pixel (instead of ca.
240Hz/Pixel) combined with a higher GRAPPA factor and a minimal number of ACS
lines ensures ‘short’ readout modules, despite the sub-millimeter resolution. As
a drawback, it results in a considerable loss of SNR that must be compensated
by signal averaging. Additionally, the phase encoding loops were swapped to
exploit the smaller acquisition dimension in phase-2D. Both recipes allow a considerable reduction of TI1
by approx. 270ms each for the given setup. Furthermore, the flip angles were
raised by 2° each. As a benefit of the short T1s, TR could be reduced to the
minimum, shortening the acquisition time without sacrificing signal.
Figure 1 shows a comparison of two
postmortem acquisitions, one with a standard 1mm isotropic MP2RAGE set up for in
vivo conditions; and one with the developed 0.75mm isotropic postmortem scheme.
Figure 2 shows examples of
intracortical lesions (i.e. lesions within the cortical layers like band-like
lesions and small punctiform lesions), leuco-cortical lesions (i.e. lesions
affecting both the cortex and the underlying white matter) and juxtacortical
lesions (i.e. lesions that are affecting the superficial white matter/u-fibers
but not the cortex), which were easily visualized by the two expert readers in
the three brains.
Figure 3 shows T1 relaxation times in intracortical, leuco-cortical and
juxtacortical lesions as well as in the corresponding normal-appearing tissues.
Coherent with MP2RAGE measurements obtained in living patients at 3T MRI3,
T1 relaxation times are significantly longer in leuco-cortical lesions compared
to the corresponding normal appearing regions, but there is no significant
difference between cortical lesions and normal-appearing GM.Discussion and Conclusion
This work shows the feasibility to
acquire postmortem MP2RAGE in a fixated brain with an optimized contrast to
detect focal cortical, leuco-cortical and juxtacortical MS lesions.
Identifying lesions within and near the
cortex is extremely challenging due to their small size and the presence of
partial-volume voxels at the border between the cortex and the underlying white
matter in clinical images3,4. MP2RAGE has shown an advantage in
detecting lesions in the cortical ribbon and nearby in living patients, mainly
thanks to its sharp contrast between white and grey matter. Moreover, MP2RAGE
provides T1 relaxometry maps that help characterizing the lesions’
microstructure3,4.
Postmortem MP2RAGE may be beneficial for several reasons including the
possibility to achieve higher spatial resolution than in in vivo scans and to compare imaging results with histopathological analysis.
Neuropathological assessment is especially challenging for cortical lesions
because areas of focal damage involving the cortex are often missed by
macroscopic examinations. MP2RAGE will provide therefore a new window into
cortical MS pathology to better identify areas that will undergo
histopathological analysis. In addition, it provides microstructural measures
that potentially relates to damage and repair phenomena in MS lesions and that
may be translated into clinical assessments.Acknowledgements
This work was funded by the Swiss National Funds PZ00P3_154508, PZ00P3_131914 and PP00P3_176984.References
1. Mugler JP 3rd, Brookeman JR. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med 1990;15(1):152-7.
2. Marques JP, Kober T, Krueger G, et al. MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field. Neuroimage 2010;49(2):1271-81.
3. Kober T, Granziera C, Ribes D, et al. MP2RAGE multiple sclerosis magnetic resonance imaging at 3 T. Invest Radiol 2012;47:346-52.
4. Beck ES, Sati P, Sethi V, et al. Improved Visualization of Cortical Lesions in Multiple Sclerosis Using 7T MP2RAGE. AJNR Am J Neuroradiol 2018;39(3):459-466.
5. Luciano NJ, Sati P, Nair G, et al. Utilizing 3D Printing Technology to Merge MRI with Histology: A Protocol for Brain Sectioning. J Vis Exp 2016 Dec 6;(118).
6. Absinta M, Nair G, Filippi M, et al. Postmortem Magnetic Resonance Imaging to Guide the Pathologic Cut: Individualized, 3-Dimensionally Printed Cutting Boxes for Fixed Brains. J Neuropathol Exp Neurol. 2014;73(8):780-8.
7. Griffin AD, Turtzo C, Parikh G, et al. Traumatic microbleeds suggest vascular injury and predict disability in traumatic brain injury. Brain 2019;142(11):3550-3564.